China Glimepiride Industry 2015 Market Report; Launched via MarketResearchReports.com

The China Glimepiride Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Glimepiride industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Glimepiride market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on China major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Glimepiride industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 142 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 139 pages “China Glimepiride Industry 2015 Market Research Report” report covers Industry Overview, Manufacturing Cost Structure Analysis of Glimepiride, Technical Data and Manufacturing Plants Analysis, Production Analysis of Glimepiride by Regions, Type, and Applications, Consumption Volume and Consumption Value Analysis of Glimepiride by Regions, Analysis of Glimepiride Production, Supply, Sales and Market Status 2010-2015, Analysis of Glimepiride Industry Key Manufacturers, Price and Gross Margin Analysis, Marketing Trader or Distributor Analysis of Glimepiride, Development Trend of Glimepiride Industry 2016-2021, Industry Chain Suppliers of Glimepiride with Contact Information, New Project Investment Feasibility Analysis of Glimepiride, Conclusion of the China Glimepiride Industry 2015 Market Research Report.

Find more information Visit at: http://mrr.cm/oXm

Related Report:

China Gliquidone Industry 2015 Market Research Report - visit at: http://mrr.cm/oXs

Asia-Pacific Multiple Myeloma Treatment Market Value Will Reach $2.8 Billion by 2021, Find New Report

The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, and Australia will rise in value from $1.7 billion in 2014 to $2.8 billion by 2021, representing a Compound Annual Growth Rate (CAGR) of 7.4%, according to new report.

The company’s latest report states that growth will primarily be driven by the emergence of novel therapeutics that have significantly improved clinical outcomes across all stages of the disease, as well as the lack of generic competition in China, Japan and Australia.

According to Senior Analyst, expects the leading brands, Revlimid, Velcade and Thalomid, to continue to perform strongly in the APAC multiple myeloma treatment space, with minimal generic competition at present.

Senior Analyst explains: “The only leading brand that faces imminent generic challenge is the proteasome inhibitor Velcade, the patent of which is expected to expire in China, Japan and Australia in 2015, 2018 and 2020, respectively. Generic versions of Velcade are already available in India.

Furthermore, there are now several options in the relapsed or refractory disease setting, which will also contribute to growth in the APAC multiple myeloma therapeutics market by 2021. These drugs include Pomalyst, which was approved in Australia and Japan in 2013, and Farydak, which was approved in Japan earlier this year.

During the forecast period, these existing treatments for multiple myeloma will be supplemented by new drugs, many of which will be used in combination with the leading brands.

Senior Analyst continues: “Kyprolis will be launched in the APAC region in the near future, Daratumumab has been trialed in combination with Revlimid and dexamethasone, and elotuzumab has been trialed in combination with Revlimid.

“These emerging multiple myeloma therapies are likely to offer alternatives in the relapsed or refractory disease setting, in both the second and third lines of treatment, further boosting APAC market growth.”

Other promising multiple myeloma pipeline drugs are Zolinza, filanesib and plitidepsin. However, no clinical trial is registered for these treatments in the APAC countries and they are only expected to launch towards the end of forecast period, according to Publisher.

Multiple Myeloma Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Velcade, Revlimid and Emerging Supplementary Treatments report provides analysis of the multiple myeloma therapeutics space across the Asia-Pacific (APAC) countries of India, China, Australia and Japan, with annualized market data from 2014 and forecast to 2021. Key topics covered include treatment usage patterns, annual therapy costs, and market growth projections for multiple myeloma treatment in the APAC region.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by Publisher’s team of industry experts.

Find more information Visit at: http://mrr.cm/oXg

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

Obesity - Identifying and Commercializing First-in-Class Innovation, New Report Launched

Highly Innovative Pipeline Could Transform Obesity Treatment Landscape

While the current obesity treatment market has a high level of unmet need, the therapeutic landscape could be transformed by a highly innovative and diverse pipeline that includes 248 products in active development, according to new report.

The company’s latest report states that despite the current market’s clinical and regulatory challenges, the obesity pipeline is robust and contains a high level of diversity in both molecule types and molecular targets, with 39% of the pipeline products with disclosed molecular targets classified as first-in-class.

Senior Analyst, says that while most pipeline products target gut hormone receptors, the remainder target a wide range of processes thought to be dysregulated in obesity, such as angiogenesis, insulin signaling, inflammation, fat absorption, lipid synthesis, and metabolism.

Senior Analyst comments: “The high level of innovation and diversity in molecular target in development is encouraging, with a number of these not only showing close alignment to the disease pathophysiology but also addressing multiple mechanisms underpinning the development of obesity.

“As obesity is a multifactorial disease, targeting multiple systems may potentially avoid compensatory mechanisms that lead to weight regain and achieve sustainable weight loss over the long term.”

The analyst adds that small molecules, accounting for 66% of the overall pipeline, are the dominant molecule type in all stages of development for obesity treatment. Biologic therapeutics, consisting largely of peptides, proteins, antibodies and vaccines, also feature prominently.

The report also states that the long-term treatment options for obesity remain sparse, including the dietary fat absorption inhibitor Xenical (orlistat), and appetite suppressants such as Qsymia (phentermine and topiramate extended release), Belviq (lorcaserin hydrochloride), and the two new market entrants Contrave (naltrexone and bupropion) and Saxenda (liraglutide rDNA origin).

Senior Analyst continues: “Prescription of these treatments is generally limited, primarily due to concerns over their long-term safety, with the past decade seeing a number of drug withdrawals in the market as a result of serious cardiovascular risks and psychiatric adverse reactions.

“The uptake of anti-obesity drugs has also been hindered by their modest efficacy in inducing sustained body weight reduction. All of these factors are driving efforts to address the significant unmet need for effective obesity therapeutics with favorable safety profiles,” the analyst concludes.

Frontier Pharma: Obesity - Identifying and Commercializing First-in-Class Innovation report provides analysis of the obesity treatment pipeline, stratified by stage of development, molecule type and molecular target. It includes information on the current clinical and commercial landscape, and the composition of the obesity therapeutics market in terms of dominant molecule types and targets, as well as highlighting current unmet needs.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by Publisher’s team of industry experts.

Find more information Visit at: http://mrr.cm/oXY

Find all Diseases Reports at: http://www.marketresearchreports.com/diseases

United States Breast X-ray Machine Industry 2015 Market Report; Launched via MarketResearchReports.com

The United States Breast X-ray Machine Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Breast X-ray Machine industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Breast X-ray Machine market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Breast X-ray Machine industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 151 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 136 pages “United States Breast X-ray Machine Industry 2015 Market Research Report” report covers Industry Overview, Manufacturing Cost Structure Analysis of Breast X-ray Machine, Technical Data and Manufacturing Plants Analysis, Production Analysis of Breast X-ray Machine by Regions, Type, and Applications, Consumption Volume and Consumption Value Analysis of Breast X-ray Machine by Regions, Analysis of Breast X-ray Machine Production, Supply, Sales and Market Status 2010-2015, Analysis of Breast X-ray Machine Industry Key Manufacturers, Price and Gross Margin Analysis, Marketing Trader or Distributor Analysis of Breast X-ray Machine, Development Trend of Breast X-ray Machine Industry 2016-2021, Industry Chain Suppliers of Breast X-ray Machine with Contact Information, New Project Investment Feasibility Analysis of Breast X-ray Machine, Conclusion of the United States Breast X-ray Machine Industry 2015 Market Research Report.

Find more information Visit at: http://mrr.cm/o8q

Related Report:

Global Flow Cytometers Industry 2015 Market Research Report - visit at: http://mrr.cm/o8c

United States Color Ultrasound Industry 2015 Market Report; Launched via MarketResearchReports.com

The United States Color Ultrasound Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Color Ultrasound industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Color Ultrasound market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Color Ultrasound industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 150 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 137 pages “United States Color Ultrasound Industry 2015 Market Research Report” report covers Industry Overview, Manufacturing Cost Structure Analysis of Color Ultrasound, Technical Data and Manufacturing Plants Analysis, Production Analysis of Color Ultrasound by Regions, Type, and Applications, Consumption Volume and Consumption Value Analysis of Color Ultrasound by Regions,  Analysis of Color Ultrasound Production, Supply, Sales and Market Status 2010-2015, Analysis of Color Ultrasound Industry Key Manufacturers, Price and Gross Margin Analysis, Marketing Trader or Distributor Analysis of Color Ultrasound, Development Trend of Color Ultrasound Industry 2016-2021, Industry Chain Suppliers of Color Ultrasound with Contact Information, New Project Investment Feasibility Analysis of Color Ultrasound, Conclusion of the United States Color Ultrasound Industry 2015 Market Research Report.

Find more information Visit at: http://mrr.cm/o7h

Related Report:

United States ECG Machine Industry 2015 Market Research Report - visit at: http://mrr.cm/o77

Global Cardiac Biomarkers Industry 2015 Market Report; Launched via MarketResearchReports.com

The Global Cardiac Biomarkers Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Cardiac Biomarkers industry.

The report provides a basic overview of the industry including definitions and classifications. The Cardiac Biomarkers market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product specification, price, cost, revenue and contact information.

With 135 the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 129 pages “Global Cardiac Biomarkers Industry 2015 Market Research Report” report covers Industry Overview, Cardiac Biomarkers International and China Market Analysis, Environment Analysis of Cardiac Biomarkers, Analysis of Revenue by Classifications, Analysis of Revenue by Regions and Applications, Analysis of Cardiac Biomarkers Revenue Market Status 2010-2015, Analysis of Cardiac Biomarkers Industry Key Manufacturers, Sales Price and Gross Margin Analysis, Marketing Trader or Distributor Analysis of Cardiac Biomarkers, Development Trend of Cardiac Biomarkers Industry 2016-2021, Industry Chain Suppliers of Cardiac Biomarkers with Contact Information, New Project Investment Feasibility Analysis of Cardiac Biomarkers, Conclusion of the Global Cardiac Biomarkers Industry 2015 Market Research Report.

Find more information Visit at: http://mrr.cm/o7B

Related Report:

Global Cell Surface Markers Industry 2015 Market Research Report - visit at: http://mrr.cm/o72

Global Protein Microarrays Industry 2015 Market Report; Launched via MarketResearchReports.com

The Global Protein Microarrays Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Protein Microarrays industry.

The report provides a basic overview of the industry including definitions and classifications. The Protein Microarrays market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product specification, price, cost, revenue and contact information.

With 146 the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 125 pages “Global Protein Microarrays Industry 2015 Market Research Report” report covers Industry Overview, Protein Microarrays International and China Market Analysis, Environment Analysis of Protein Microarrays, Analysis of Revenue by Classifications, Analysis of Revenue by Regions and Applications, Analysis of Protein Microarrays Revenue Market Status 2010-2015, Analysis of Protein Microarrays Industry Key Manufacturers, Sales Price and Gross Margin Analysis, Marketing Trader or Distributor Analysis of Protein Microarrays, Development Trend of Protein Microarrays Industry 2016-2021, Industry Chain Suppliers of Protein Microarrays with Contact Information, New Project Investment Feasibility Analysis of Protein Microarrays, Conclusion of the Global Protein Microarrays Industry 2015 Market Research Report.

Find more information Visit at: http://mrr.cm/o8J

Related Report:

Global Sublingual Tablets Industry 2015 Market Research Report - visit at: http://mrr.cm/o83

Global Syphilis Testing Market to grow at a CAGR of 4.71% during 2014 - 2019; Finds New Report

Report forecast the global syphilis testing market to grow at a CAGR of 4.71% over the period 2014-2019.

Syphilis is a type of sexually transmitted infections disease caused by the bacteria Treponema pallidum subspecies pallidum. The infection spreads mainly through sexual contact. Congenital syphilis, however, affects infants by transmission of the infection from the infected mother to the fetus. The rate of syphilis infection is high among men and particularly in those men who have sex with men. In 2014, around 36 million people worldwide were infected by syphilis. The global burden of syphilis is gradually increasing. Unprotected sex and sexual intercourse with multiple partners, affected by syphilis infection are the key factors contributing to the spread of this infection. However, early diagnosis of the infection enables quick recovery from the disease. Testing methods employed for syphilis detection includes enzyme immunoassay (EIA) test, venereal disease research laboratory (VDRL) test, rapid plasma reagin (RPR) test, and point of care (POC) test kits.

In this report the present scenario and growth prospects of the global syphilis testing market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of the following product categories:

• POC syphilis test
• Conventional syphilis test (non-treponemal serology and treponemal serology test)

Global Syphilis Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, EMEA, and the Americas; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

• Americas
• APAC
• EMEA

Key vendors

• Abbott Diagnostic
• Alere
• Beckman Coulter
• Roche Diagnostics
• Siemens Healthcare

Other prominent vendors

• AccuBioTech
• Becton Dickinson and Company
• bioLytical Laboratories
• Bio-Rad Laboratories
• Chembio Diagnostic Systems
• Diasorin
• DRG International
• Grifols
• IBL International
• MedMira
• Omega Diagnostics
• Trinity Biotech
• ulti med Products
• ZEUS Scientific

Key market driver

• Increasing prevalence and incidence of syphilis
• For a full, detailed list, view our report

Key market challenge

• Discrepancies associated with the syphilis test results
• For a full, detailed list, view our report

Key market trend

• Advances in technology
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2019 and what will the growth rate be
• What are the key market trends
• What is driving this market
• What are the challenges to market growth
• Who are the key vendors in this market space
• What are the market opportunities and threats faced by the key vendors
• What are the strengths and weaknesses of the key vendors

Spanning over 70 pages “Global Syphilis Testing Market 2015-2019” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Syphilis test application, Market segmentation by technology, Market segmentation by product, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

Find more information Visit at: http://mrr.cm/o86

Related Reports:

Global Bone and Mineral Diagnostic Testing Market 2015-2019 - visit at: http://mrr.cm/o8u

Global Geriatric Care Devices Market 2015-2019 - visit at: http://mrr.cm/o8L

Global Intravenous Access Devices Market to grow at a CAGR of 7.24% during 2014 - 2019; Finds New Report

Report forecast the global intravenous access devices market to grow at a CAGR of 7.24% during 2014-2019.

Intravenous access devices are used for the rapid delivery of nutrients, fluids, and drugs such as antibiotics, analgesics, and antipyretics to a patient. It is also used for blood transfusion and the correction of electrolyte imbalance. Intravenous access devices include central venous catheters and peripheral intravenous catheters.

This report covers the present scenario and growth prospects of the global intravenous access devices market for 2015-2019. To calculate the market size, the report considers the revenue generated from sales of the following segments: Central venous catheters and peripheral intravenous catheters.

Global Intravenous Access Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also covers the landscape of the global intravenous access devices market and its growth prospects during the forecast period. The report includes a discussion on the key vendors operating in this market.

Key regions

• Americas
• APAC
• EMEA

Key vendors

• AngioDynamics
• B. Braun Melsungen
• Becton, Dickinson, and Company
• C.R.Bard
• Smiths Medical

Other prominent vendors

• Argon Medical Devices
• Boston Scientific
• Covidien
• Edwards Lifesciences
• Medical Components
• Teleflex
• Terumo
• Vascular Pathways
• VIGMED
• Vygon

Market driver

• Advances in technology
• For a full, detailed list, view our report

Market challenge

• Complications related to intravenous access devices
• For a full, detailed list, view our report

Market trend

• Increased use of antimicrobial intravenous access devices
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2019 and what will the growth rate be
• What are the key market trends
• What is driving this market
• What are the challenges to market growth
• Who are the key vendors in this market space
• What are the market opportunities and threats faced by the key vendors
• What are the strengths and weaknesses of the key vendors

Spanning over 70 pages “Global Intravenous Access Devices Market 2015-2019” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Market segmentation by product, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

Find more information Visit at: http://mrr.cm/o87

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices

Global Cancer Biomarkers Industry 2015 Market Report; Launched via MarketResearchReports.com

The Global Cancer Biomarkers Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Cancer Biomarkers industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Cancer Biomarkers market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Cancer Biomarkers industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 165 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 152 pages “Global Cancer Biomarkers Industry 2015 Market Research Report” report covers Industry Overview, Manufacturing Cost Structure Analysis of Cancer Biomarkers, Technical Data and Manufacturing Plants Analysis of Cancer Biomarkers, Production Analysis of Cancer Biomarkers by Regions, Type, and Applications, Consumption Volume and Consumption Value Analysis of Cancer Biomarkers by Regions, Analysis of Cancer Biomarkers Production, Supply, Sales and Market Status 2010-2015, Analysis of Cancer Biomarkers Industry Key Manufacturers, Price and Gross Margin Analysis of Cancer Biomarkers, Marketing Trader or Distributor Analysis of Cancer Biomarkers, Development Trend of Cancer Biomarkers Industry 2016-2021, Industry Chain Suppliers with Contact Information of Cancer Biomarkers, New Project Investment Feasibility Analysis of Cancer Biomarkers, Conclusion of the Global Cancer Biomarkers Industry 2015 Market Research Report.

Find more information Visit at: http://mrr.cm/oh8

Related Report:

North America Gastrointestinal OTC Drugs Industry 2015 Market Research Report - visit at: http://mrr.cm/ohX

Global Insulin Lispro Industry 2015 Market Report; Launched via MarketResearchReports.com

The Global Insulin Lispro Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Insulin Lispro industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Insulin Lispro market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Insulin Lispro industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 173 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 157 pages “Global Insulin Lispro Industry 2015 Market Research Report” report covers Industry Overview, Manufacturing Cost Structure Analysis of Insulin Lispro, Technical Data and Manufacturing Plants Analysis of Insulin Lispro, Production Analysis of Insulin Lispro by Regions, Type, and Applications, Consumption Volume and Consumption Value Analysis of Insulin Lispro by Regions, Analysis of Insulin Lispro Production, Supply, Sales and Market Status 2010-2015, Analysis of Insulin Lispro Industry Key Manufacturers, Price and Gross Margin Analysis of Insulin Lispro, Marketing Trader or Distributor Analysis of Insulin Lispro, Development Trend of Insulin Lispro Industry 2016-2021, Industry Chain Suppliers with Contact Information of Insulin Lispro, New Project Investment Feasibility Analysis of Insulin Lispro, Conclusion of the Global Insulin Lispro Industry 2015 Market Research Report.

Find more information Visit at: http://mrr.cm/ohc

Related Report:

Global Metformin Industry 2015 Market Research Report - visit at: http://mrr.cm/ohp

Global Respiratory Disease Testing Market to grow at a CAGR of 7.46% during 2014-2019, Finds New Report

Report forecast the global respiratory disease testing market to grow at a CAGR of 7.46% over the period 2014-2019.

The respiratory system of the body plays a vital role in eliminating carbon dioxide and toxic wastes, regulates the temperature, and establishes a stabilized blood acid-alkaline balance. Respiratory diseases such as asthma, bronchitis, COPD occur due to acute or chronic defects in the respiratory system. The respiratory testing devices help in detecting chronic or acute respiratory diseases; therefore, the necessary treatment can be provided to people suffering from respiratory damages.

Respiratory tests such as imaging, spirometry, peak flow test, blood gas test, lung volume, and few other tests are used to diagnose the respiratory disease. Globally, there has been growing incidences of respiratory diseases such as asthma and COPD. Around 235 million people globally are suffering from asthma, and there have been around 3 million deaths worldwide due to COPD. This indicates an alarming increase in the respiratory disorders worldwide due to high pollution and increased tobacco consumption.

These factors result in increased demand for the respiratory testing devices and propel the market growth.

The report covers the current scenario and the growth prospects of the global respiratory disease testing market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of testing devices used to diagnose acute and chronic respiratory diseases.

The market is segmented based on the type of test:

Mechanical/screening tests

• Spirometry test
• Peak flow test
• Blood gas test
• Lung volume test
• OSA diagnostic tests

IVD tests

• Molecular diagnostic test
• POC test
• Others

Global Respiratory Disease Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA, and APAC; it also covers the landscape of the global respiratory disease testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

According to the report, the consumption of tobacco, particularly in the form of cigarettes, is a major cause of chronic respiratory diseases worldwide. Annually, tobacco consumption results in about six million deaths worldwide. Of this number, about five million individuals die due to direct tobacco consumption while 0.6 million people die due to passive smoking. Research studies report that tobacco consumption is high in developing countries compared to developed countries.

Key regions

• Americas
• APAC
• EMEA

Key Global Respiratory Disease Testing Market:  Alere, CareFusion, COSMED, Nihon Kohden, Philips Healthcare and Smiths Medical

Other Prominent Vendors in the market are: Diamedix, Affymetrix, Seegene, Cepheid, NDD Medical Technologies, COSMED, Abbott, F. Hoffmann-La Roche, Siemens Healthcare, Instrumentation Laboratories, Covidien, SDI Diagnostics, and Futuremed America.

Key market driver

• Increase in respiratory disorders worldwide
• For a full, detailed list, view our report

Key market challenge

• Use of low-cost testing products
• For a full, detailed list, view our report

Key market trend

• Initiatives and programs to create awareness
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 66 pages “Global Respiratory Disease Testing Market 2015-2019” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Market segmentation by test, Market segmentation by mechanical and screening test, Market segmentation by IVD test, Geographical segmentation, Market drivers, Impact of drivers, Market challenge, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

Find more information Visit at: http://mrr.cm/on2

Related Reports:

Global Antibacterial Drugs Market 2015-2019 - visit at: http://mrr.cm/on6

Global Drug Device Combination Products Market 2015-2019 - visit at: http://mrr.cm/onu

Global Hormone Replacement Therapy Market 2015-2019 - visit at: http://mrr.cm/onL

Global Intrauterine Devices Market 2015-2019 - visit at: http://mrr.cm/onb